Skip to content

Author

M. Ravi Kumar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

From acute intervention to chronic management: Biopharmaceutical barriers and advanced formulation strategies for Peroral metronomic chemotherapy.

Although cancer is a chronic disease, conventional oncology has largely relied on maximum tolerated dose (MTD) chemotherapy to achieve rapid tumor killing. However, the limited specificity of these agents frequently results in substantial systemic toxicity and necessitates prolonged treatment-free intervals that may pe...

Yirivinti Hayagreeva Dinakar, R. Ganugula, A. Sood et al. · 0 citations
Aug 2026

Cyclosporine-A Nanotherapeutics Ameliorate Lupus Nephritis by Reprogramming the Gut-Microbial Metabolic Axis and Systemic Inflammation.

Systemic lupus erythematosus (SLE) is a debilitating autoimmune disease fueled by abnormal immune responses and metabolic dysregulation, often leading to life-threatening lupus nephritis (LN). While Cyclosporine A (CsA) is a potent therapeutic agent, its clinical utility is severely constrained by systemic off-target t...

K. T. Babalola, R. Ganugula, M. Arora et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.